There has been much discussion about the role of platelets in the pathogenesis of migraine. A new in vitro technique using a custom built device called the Haemostatometer measures haemostasis, thrombolysis, and coagulation from non-anticoagulated, undiluted (native) blood. Using this device, data were analysed from blood samples taken from 10 migraineurs between attacks and 10 control subjects. Results showed no difference in haemostasis, spontaneous thrombolysis or coagulation between migraineurs and control subjects.
Get full access to this article
View all access options for this article.
References
1.
HaningtonE.Migraine: a blood disorder?Lancet1978;11:501–3.
2.
PetersNSAbramsLSMDymondDSKovacsIB.Platelet hyperreactivity and inefficient spontaneous thrombolysis in patients at high risk from an acute coronary event.Cardiovasc Res1989;23:567–72.
3.
GorogPKovacsIB.Prostacyclin is a more potent stimulator of thrombolysis than inhibitor of haemostasis.Haemostasis1986;16:337–45.
4.
HaningtonEJonesRJAmesJALWachowiczB.Migraine: a platelet disorder.Lancet1981;ii:720–3.
5.
HiltonBPCumingsJN.An assessment of platelet aggregation induced by 5-hydroxytryptamine.J Clin Pathol1971;24:250–8.
6.
HsuLKGCrispAHKalucyRSKovalJChenCNCarruthersMZilkhaKJ.Early morning migraine--nocturnal plasma levels of catechol-amines, tryptophan, glucose and free fatty acids and sleep encephalographs.Lancet1977;1:447–51.
7.
SicuteriFTestiAAnselmiB,Biochemical investigations in headache: increase in the hydroxy-indoleacetic acid secretion during migraine attacks.Int Arch Allergy Appl Immunol1961;19:55–8.
8.
AnthonyMHinterbergerHLanceJW.Plasma serotinin in migraine and stress.Arch Neurol1967;16:544–52.
9.
CurranDAHinterbergerHLanceJW.Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid secretion in normal and migrainous subjects.Brain1965;88:997–1010.
10.
BornGVRMillsDCBSmithJB.Pharmacology of inhibition of platelet aggregation.Bull Schweiz Akad Med Wiss1973;29:215–22.
11.
HarfenistE JPackhamMAKinlough-RathboneRLCattenoMMustardJF.Effect of calcium ion concentration on the ability of fibrinogen and yon Willebrand factor to support the ADP-induced aggregation of human platelets.Blood1987;70:827–31.
12.
PackhamMAKinlough-RathboneRLMustardJF.Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionised calcium.Blood1987;70:647–51.
13.
KeralyCLKinlough-RathboneRLPackhamMASuzukiHMustardJF.Conditions affecting the responses of human platelets to epinephrine.Throm Haemost1988;60:209–16.
14.
McLeanMRHauseLL.The effect of bovine lung heparin on normal human platelets as measured by electronic particle size analysis.Thromb Haemost1982;47:5–7.
15.
KovacsIBHuttonRAKernoffPBA.Hemostatic evaluation in bleeding disorders from native blood.Am J Clin Pathol1989;91:271–9.
16.
KaneshiroMMMielkeCHKasperCKRapaportSI.Bleeding time after aspirin in disorders of intrinsic clotting.N Engl J Med1969;281:1039–42.
17.
.Headache classification committee of the international headache society.Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.Cephalalgia1988;8(suppl 7):1–96.
18.
HarkerLASlichterSS.The bleeding time as a screening test for evaluation of platelet function.N Engl J Med1972;287:155–9.
19.
MielkeCH.Mechanisms of hemostasis and thrombosis.Miami, USA:Symposia Specialists Inc1978:31.
